Titlebook: ;

constitutional

阐明

Gut Microbiome and Hepatic Steatosis (Steatotic Liver Disease),ent outcomes. This chapter summarizes our current knowledge on the role of the gut–liver axis in hepatic steatosis and provides information on microbiota-targeted interventions that may be able to ameliorate or treat hepatic steatosis in the future.

Lipoprotein

Gut Microbiota and Type 2 Diabetes Mellitus,o be associated with T2DM. The human gut microbiota can be considered an organ with important functions for human metabolism, digestion, maintenance of the intestinal barrier function, and immunomodulation. It helps to modulate host metabolism and its change appears to be related to the development

格子架

Archipelago

Gut Microbial Metabolism in Heart Failure, research has illustrated the effects of several gut microbial metabolites such as short-chain fatty acids, bile acids, trimethylamine .-oxide, amino acid metabolites, and phenylacetylglutamine and their implications in HF pathogenesis and overall cardiac health. The use of gut microbial metabolites

欢呼

Expressly

Gut Microbiota and Diabetic Kidney Diseases,pathobionts and is associated with a significant increase in uremic solutes and inflammatory mediators that gradually intensify kidney damage, creating a vicious cycle in which dysbiosis and renal dysfunction are progressively worsened. Novel strategies aimed at targeting the intestinal microbiome i

胶状

capillaries

cochlea

The Role of Endothelial Dysfunction in the Connection Between Gut Microbiota, Vascular Injury, and that there is a substantial contribution to this process accompanying altered microbiota. This occurs via an enhanced endotoxin migration from the epithelial intestinal barrier (LPS in particular), which leads to low-grade endotoxemia. This, in turn, is associated with increased cytokine release, d